Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

Creutzfeldt W (1979) The incretin concept today. Diabetologia 16: 75–85

Unger RH, Eisentraut AM (1969) Entero-insular axis. Arch Int Med 123: 261–266

Seltzer HS, Allen EW, Herron AL Jr, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: Relation of delayed initial response to carbohydrate intolerance in mild diabetes. J Clin Invest 45: 323–335

Cerasi E, Luft R (1967) the plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 55: 278–304

Reaven GM, Farquhar JW (1969) Steady state plasma insulin response to continuous glucose infusion in normal and diabetic subjects. Diabetes 18: 273–279

Nauck M, Homberger E, Siegel EG, Ebert R, Creutzfeldt W (1985) Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. Diabetes Res Clin Pract 9 (Suppl 1): S403 (Abstract)

Faber OK, Madsbad S, Kehlet H, Binder C (1979) Pancreatic beta cell secretion during oral and intravenous glucose administration. Acta Med Scand (Suppl) 624: 61–64

Gibby OM, Hales CN (1983) Oral glucose decreases hepatic extraction of insulin. Br Med J 286: 921–923

Madsbad S, Kehlet H, Hilsted J, Tronnier B (1983) Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose. Diabetes 32: 436–438

Perley MJ, Kipnis D (1967) Plasma insulin responses to oral and intravenous glucose: Studies in normal and diabetic subjects. J Clin Invest 46: 1954–1962

Crockett SE, Mazzaferri EC, Cataland S (1976) Gastric Inhibitory Polypeptide (GIP) in maturity-onset diabetes mellitus. Diabetes 25: 931–935

Ebert R, Frerichs H, Creutzfeldt W (1976) Serum Gastric Inhibitory Polypeptide (GIP) responses in patients with maturity onset diabetes and in juvenile diabetes. Diabetologia 12: 388 (Abstract)

Ross SA, Brown JC, Dupre J (1977) Hypersecretion of Gastric Inhibitory Polypeptide following oral glucose in diabetes mellitus. Diabetes 26: 525–529

Salera M, Giacomoni P, Pironi L, Cornia G, Capulli M, Marini A, Benfenati F, Miglioli M and Barbara C (1982) Gastric Inhibitory Polypeptide release after oral glucose: Relationship to glucose intolerance, diabetes mellitus and obesity. J Clin Endocrinol Metab 55: 329–336

Ebert R, Creutzfeldt W (1980) Hypo- and hypersecretion of GIP in maturity-onset diabetics. Diabetologia 19: 271–272 (Abstract)

Bloom SR (1975) GIP in diabetes (abstract). Diabetologia 11: 334

May JM, Williams RH (1978) The effect of endogenous Gastric Inhibitory Polypeptide on glucose-induced insulin secretion in mild diabetes. Diabetes 27: 849–855

Creutzfeldt W, Ebert R, Nauck M, Stöckmann F (1983) Disturbances of the entero-insular axis. Scand J Gastroenterol 18 (Suppl 82): 111–119

WHO Expert Committee on Diabetes Mellitus, Second Report, Technical Report Series 646, WHO, Geneva, 1980

Ito C, Mito K, Hara H (1983) Review of criteria for diagnosis of diabetes mellitus based on results of follow-up study. Diabetes 28: 1039–1057

National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057

Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D, Andres R (1983) Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32: 106–111

Melani F, Ditschuneit H, Bartelt HM, Friedrich H, Pfeiffer EF (1965) Über die radioimmunologische Bestimmung von Insulin im Blut. Klin Wochenschr 43: 1000–1006

Heding LG (1975) Radioimmunological determination of human C-peptide. Diabetologia 11: 541–548

Kuzio M, Dryburgh JR, Malloy KM, Brown JC (1974) Radioimmunoassay for gastric inhibitory polypeptide. Gastroenterol 66: 357–364

Ebert R, Illmer K, Creutzfeldt W (1979) Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Gastroenterol 76: 515–523

Waldhaeusl W, Bratusch-Marrain P, Gasic B, Korn A, Nowotny P (1979) Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17: 221–227

Honey RN, Price S (1979) The determinants of insulin extraction in the isolated perdused rat liver. Horm Metab Res 11: 111–117

Tranberg KG (1979) Hepatic uptake of insulin in man. Am J Physiol 237: E509–518

Madison LL, Kaplan N (1958) The hepatic binding of I-131 labeled insulin in human subjects during a single transhepatic circulation. J Lab Clin Med 52: 927–932

Kuzuya T, Matsuda A (1976) Disappearance rate of endogenous human C-peptide from blood. Diabetologia 12: 519–521

Polonsky K, Jaspan J, Pugh W, Cohen D, Schneider T, Schwartz T, Moossa AR, Tager H, Rubenstein AH (1983) Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest 72: 1114–1123

Polonsky K, Rubenstein AH (1984) C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 33: 486–493

Rubenstein AH, Clark JL, Melani F, Steiner DF (1969) Secretion of proinsulin C-peptide by pancreaticβ-cells and its circulation in blood. Nature 224: 697–699

Faber OK, Hagen C, Binder C, Markussen J, Naithani VK, Blix PM, Kuzuya H, Horwitz DL, Rubenstein AH, Rossing N (1978) Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 62: 197–203

Halter JB, Graf RJ, Porte D Jr. (1979) Potentiation of insulin secretory responses by plasma glucose levels in man: Evidence that hyperglycaemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48: 946–954

Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG (1985) The effect of insulin treatment on insulin secretion and insulin action in type 2 diabetes mellitus. Diabetes 34: 222–234

Kimmerling G, Javorski WC, Olefsky JM, Reaven GM (1976) Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus. Diabetes 25: 673–678

Jaspan J, Polonsky K (1982) Glucose ingestion in dogs alters the hepatic extraction of insulin: In vivo evidence for a relation between biologic action and extraction of insulin. J Clin Invest 69: 516–525

Ross SA, Brown JC, Dupre J (1974) Effects of Gastric Inhibitory Polypeptide on endocrine pancreas in normal and diabetic subjects. Diabetologia 10: 384 (Abstract)

Krarup T, Moody AJ, Saurbrey N, Kühl C, Madsbad S (1984) Effect of porcine gastric inhibitory polypeptide onβ-cell-function in type 1 (insulin dependent) and type 2 (non-insulin-dependent) diabetes. Diabetologia 27: 299 (Abstract)

Ebert R, Creutzfeldt W (1982) Influence of Gastric Inhibitory Polypeptide antiserum on glucose-induced insulin secretion in rats. Endocrinol 111: 1601–1606

Ebert R, Unger H, Creutzfeldt W (1983) Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption. Diabetologia 24: 449–454